| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |